← Home
Novartis 
Pharma / Pharmaceuticals and Healthcare
Risks
1. Patent Expiration: The expiration of patents on key drugs is a major risk for Novartis, as it could lead to a loss of revenue when generics enter the market and reduce prices.
2. Competitive Pressure: Growing pressure from competitors could force Novartis to reduce prices, leading to lower revenues and profits.
3. Litigation Risk: Novartis has been and continues to be involved in various lawsuits, some of which have resulted in financial settlements.
4. Macroeconomic Risk: Novartis is dependent on the global economy and is subject to risk from fluctuations in foreign exchange rates, commodity prices, and other macroeconomic factors.
5. Strategic Risk: Strategic decisions can result in huge rewards, but when they are wrong, they can have long-term negative repercussions.